Shea’s term began July 1, 2012 and will last until June 30, 2016.
The appointment “represents recognition by the Oncology research community for my efforts in promoting clinical and translational research in the field,” Shea said. “I consider it an honor, but it will also mean a lot of work.”
NIH study section membership requires proficiency as seen through the subject’s research, publications in scientific journals as well as other scientific achievements.
In these four years, Shea’s work will involve reviewing grant applications submitted to the NIH and making recommendations on these applications to an NIH advisory council while monitoring research done in their field of science. The section will meet three times a year where Shea will be the primary or secondary reviewer for five to ten cancer and cancer immunology related grants at each session. Each session may review 100 or more applications.
“This is the best way to keep abreast of exciting and promising research in the field and should provide me with an opportunity to provide input into the direction that the highest level of investigation on a nationwide basis will take,” he said.
Dr. Shea also serves as chair of the Scientific Advisory Committee for the Center for International Blood and Marrow Transplant Research (CIBMTR). He is a member of UNC Lineberger.